교수진 소개
- Name
- Yeon-Joo KIM, M.D., Ph.D.
- Faculty Appointment
(title, department)
- Associate Professor,
Department of Cancer Biomedical Science Staff physician,
Proton Therapy Center,
National Cancer Center Hospital Research Scientist,
National Cancer Center Research Institute
- Area of Expertise
- Radiation Oncology (Breast & Gynecology)
- Contact no
- +82-31-920-1785
- E-mail
- yjkim1785@ncc.re.kr
- Work Experience
-
2006-2007 Internship, Seoul National University Hospital, Korea
2007-2011 Residency, Department Radiation Oncology, Seoul National University Hospital, Korea
2011-2013 Clinical fellowship, Proton Therapy Center, National Cancer Center Hospital, Korea
2013.3-present Staff physician, Proton Therapy Center, National Cancer Center Hospital, Korea
- Educational Background
-
2000-2006 Seoul National University College of Medicine, Korea, Degree: M.D.
2009-2011 Department Radiation Oncology, Graduate School, Seoul National University College of Medicine, Korea, Degree: M.S.
2011-2021 Department Radiation Oncology, Graduate School, Seoul National University College of Medicine, Korea, Degree: Ph.D.
- Research Interests
-
Breast cancer, Gynecology cancer, Radiation oncology, Radiation biology, Radiation physics
- International Collaboration
-
KOSTRO (The Korean Society for Therapeutic Radiology & Oncology) member
KCA (Korean Cancer Association) member
KBCS (Korean Breast Cancer Society) member
KSGO (Korean Society of Gynecologic Oncology) member
- Achievements
-
Awards
Merit Award, 10th International Conference of the Asian Clinical Oncology Society (Title: A phase II study of hypofractionated proton therapy for prostate cancer)(May 2012)
Best Presentation Award, 10th Global Breast Cancer Conference
(Title: Dummy run of quality assurance program in a prospective cohort study investigating the effect of regional nodal irradiation on the regional recurrence rate in ypN0 breast cancer patients: KROG 19-09)(April 2021)
Publications
2021
SCI-E
Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis: CANCERS. 13(15):3703~ (6.639)
2021
SCI-E
Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea: JOURNAL OF GYNECOLOGIC ONCOLOGY. 32:e85~ (4.401)
2021
SCI-E
Evaluation of the dosimetric effect of scattered protons in clinical practice in passive scattering proton therapy: JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS. 22(6):104~118 (2.102)
2021
SCI-E
Reduction of superficial radiation dose with bolus in passive scattering proton beam therapy: JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS. 22(2):69~76 (2.102)
2020
SCI-E
Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30(6):764~771 (2.095)
2019
SCI-E
Clinical Significance of Lymph-Node Ratio in Determining Supraclavicular Lymph-Node Radiation Therapy in pN1 Breast Cancer Patients Who Received Breast-Conserving Treatment (KROG 14-18): A Multicenter Study: CANCERS. 11(5):E680~E680 (6.162)
2019
SCI-E
Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation: RADIATION ONCOLOGY. 14(1):4~4 (2.895)
2019
SCI-E
Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418): CANCER RESEARCH AND TREATMENT. 51(3):1041~1051 (3.23)
2018
SCI
Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial: Gynecologic oncology. 151(1):39~45 (4.54)
2018
SCI
Treatment Results and Prognostic Factors of Brain Metastases From Ovarian Cancer: International journal of gynecological cancer. 28(8):1631~1638 (2.192)
2017
SCI-E
Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.: Cancer Research and Treatment. 50(2):335~344 (3.772)
2017
SCI
Independent dose verification system with Monte Carlo simulations using TOPAS for passive scattering proton therapy at the National Cancer Center in Korea: Physics in Medicine & Biology. 62(19):7598~7616 (2.742)
2017
SCI-E
Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline plus Taxane-based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study: Cancer Research and Treatment. 49(4):970~980 (3.772)
2017
SCI
General health status of long-term cervical cancer survivors after radiotherapy: Strahlentherapie Und Onkologie. 193(7):543~551 (2.735)
2017
SCI
Proton radiography and computed tomography with dynamic water range shifter: Journal of Instrumentation. 12:4004~4004 (1.22)
2016
SCI-E
Post-mastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).: Cancer Research and Treatment. Online:Published (4.245)
2016
SCI-E
Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer: Brachytherapy. 16(1):116~125 (2.088)
2016
SCI-E
Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418): Oncotarget. 8(1):1796~1804 (5.008)
2016
SCI
Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.: Strahlentherapie und Onkologie. 192(12):922~930 (2.898)
2016
SCI-E
Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis After Resection of Brain Metastases in Breast Cancer Patients: Cancer Research and Treatment. Online:Published (4.245)
2016
SCI-E
Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer: Cancer Research and Treatment. 48(4):1330~1337 (4.245)
2016
SCI-E
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment: Cancer research and treatment. 48(4):1363~1372 (4.245)
2016
SCI
Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial: Radiotherapy and Oncology. 120(3):383~389 (4.817)
2016
SCI
Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas: Strahlenther Onkol. 192(9):649~657 (2.898)
2016
SCI
A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer: Medicine. 95(19):e3320~e3320 (2.133)
2016
SCI
Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer: International Journal of Gynecological Cancer. 26(4):737~742 (2.116)
2015
SCI-E
Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer: Cancer research and treatment. 48(2):641~649 (3.318)
2015
SCI
Radical prostatectomy versus external beam radiotherapy for localized prostate cancer : Comparison of treatment outcomes.: Strahlentherapie und Onkologie. 191(4):321~329 (2.914)
2015
SCI-E
Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma.: Cancer research and treatment. 47(1):34~45 (3.318)
2014
SCI-E
The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy: Radiation oncology [electronic resource]. 9:283~283 (2.36)
2014
SCI
Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma: Strahlentherapie und Onkologie. 190(10):882~890 (2.733)
2014
SCI
Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.: Strahlentherapie und Onkologie. 190(9):806~814 (2.733)
2013
SCI-E
Dosimetric Evaluation of Magnetic Resonance Imaging-based Intracavitary Brachytherapy for Cervical Cancer: Technology in Cancer Research and Treatment. 13(3):243~251 (1.886)
2013
SCI
The volumetric change and dose-response relationship following hypofractionated proton therapy for chordomas: Acta Oncologica. 53(4):563~568 (3.71)
2013
SCI
Phase II trial of proton beam accelerated partial breast irradiation in breast cancer: Radiotherapy and Oncology. 108(2):209~214 (4.52)
2013
SCI-E
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer: Radiation Oncology. 8(1):160~160 (2.107)
2013
SCI
The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy: Radiotherapy and Oncology. 1081(1):168~173 (4.52)
2013
SCI
Retrospective analysis of treatment outcome of pediatric ependymomas in Korea: analysis of Korean multi-institutional data.: Journal of Neuro-oncology. 113(1):39~48 (3.115)
2013
SCI
A phase II study of hypofractionated proton therapy for prostate cancer.: Acta Oncologica. 52(3):477~485 (2.867)
2013
SCI-E
High Control Rate for Lymph Nodes in Cervical Cancer Treated with High-dose Radiotherapy using Helical Tomotherapy: Technology in Cancer Research and Treatment. 12(1):45~51 (1.943)
2013
SCI
Combined Primary Tumor and Extracranial Metastasis Status as Constituent Factor of Prognostic Indices for Predicting the Overall Survival in Patients with Brain Metastases: Journal of Korean medical science. 28(2):205~212 (1.249)
2013
SCI-E
A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy: Radiation Oncology. 8:28~28 (2.107)
2012
SCI
Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection.: International journal of radiation oncology, biology, physics.. 84:e585~e592 (4.105)
2012
SCI
No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients: Clinica Chimica Acta. 413(3-4):511~515 (2.535)
2011
SCI
Single-Dose Versus Fractionated Stereotactic Radiotherapy for Brain Metastases: International Journal of Radiation Oncology, Biology and Physics. 81(2):483~489 (4.503)
2011
SCI
Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy: HEAD & NECK. 33:1458~1466 (2.182)
